Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers
NCT ID: NCT05933772
Last Updated: 2025-03-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2023-08-18
2023-12-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance of Toric Silicone Hydrogel Contact Lenses
NCT05097144
To Evaluate The Performance Of Two Monthly Replacement Silicone Hydrogel Contact Lenses After 1-month Of Wear
NCT05333965
Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use
NCT05166902
Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses
NCT05805059
Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types
NCT06232590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lens A, Then Lens B
Participants will wear Lens A for one month and then crossover to Lens B for one month.
Lens A (comfilcon A toric lens)
One month wear
Lens B (lehfilcon A toric lens)
One month wear
Lens B, Then Lens A
Participants will wear Lens B for one month and then crossover to Lens A for one month.
Lens A (comfilcon A toric lens)
One month wear
Lens B (lehfilcon A toric lens)
One month wear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lens A (comfilcon A toric lens)
One month wear
Lens B (lehfilcon A toric lens)
One month wear
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Has read and signed an information consent letter;
3. Self-reports having a full eye examination in the previous two years;
4. Anticipates being able to wear the study lenses for at least 8 hours a day, 6 days a week;
5. Is willing and able to follow instructions and maintain the appointment schedule;
6. Habitually wears of toric soft contact lenses binocularly.
1. No more than 1/3 of the participants should be wearing daily disposable soft toric lenses;
2. the remaining 2/3+ of the participants must be planned frequent replacement soft toric lens wearers as follows:
* i. TOTAL30 for Astigmatism: maximum of 3 (∼10%) (no target percentage)
* ii. Biofinity toric: maximum of 13 (∼40%) (PLUS a target of minimum 10 (∼30%))
* iii. Air Optix for Astigmatism (inclusive of +Hydraglyde): maximum of 10 (∼30%) (PLUS a target of minimum 7 (∼20%))
* iv. ULTRA for Astigmatism: maximum of 5 (∼15%) (no target percentage)
* v. Acuvue Vita for Astigmatism: maximum of 3 (∼10%) (no target percentage)
* vi. Acuvue Oasys for Astigmatism: maximum of 10 (∼30%) (no target percentage)
* vii. Other brands of frequent replacement: maximum of 7 (∼20%) (no target percentage)
7. Has refractive astigmatism of at least -0.75DC but no more than -2.75DC in each eye that is correctable with a soft toric lens with a cylinder power of no greater than -2.25DC;
8. Is ammetropic and requires a spectacle spherical component of +8.00 to -10.00D inclusively;
9. Can be fit and achieve binocular distance vision of at least 20/32 Snellen with the available lens parameters
Exclusion Criteria
2. Has any known active ocular disease and/or infection that contraindicates contact lens wear;
3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
4. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
5. Has known sensitivity to the diagnostic sodium fluorescein used in the study;
6. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
7. Has undergone refractive error surgery or intraocular surgery.
18 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre for Ocular Research & Education, Canada
OTHER
CooperVision International Limited (CVIL)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Sacco
Role: PRINCIPAL_INVESTIGATOR
Sacco Eye Group
David Wilkinson
Role: PRINCIPAL_INVESTIGATOR
Spadina Optometry
Fiona Soong
Role: PRINCIPAL_INVESTIGATOR
Eyes on Sheppard Clinic
Katherine Bickle
Role: PRINCIPAL_INVESTIGATOR
ProCare Vision Center
Shane R. Kannarr
Role: PRINCIPAL_INVESTIGATOR
Kannarr Eye Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kannarr Eye Care
Pittsburg, Kansas, United States
Sacco Eye Group
Vestal, New York, United States
ProCare Vision Center
Granville, Ohio, United States
Eyes on Sheppard Clinic
Toronto, Ontario, Canada
Spadina Optometry
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.